Related Experiment Video
Updated: Aug 6, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
The relative immunogenicity of 20-valent and 15-valent pneumococcal conjugate vaccines: A systematic review and
Ilaria Valentini1,2, Erika Alessandra Strangi3, Gaia Baccarini2
1Graduate School of Health Economics and Management (ALTEMS), Università Cattolica del Sacro Cuore, Rome, Italy.
Insights
Pneumococcal conjugate vaccines (PCV) comparisons in adults show PCV15 elicits stronger immune responses than PCV20 for most shared serotypes, particularly in older adults. Further direct comparative studies are recommended.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Pneumococcal conjugate vaccines (PCV) are crucial for preventing pneumococcal disease in adults.
- Higher-valent PCVs aim to broaden protection, but direct comparisons between PCV20 and PCV15 in adults are lacking.
Conclusions:
- PCV15 appears to elicit a more robust immune response than PCV20 for most shared serotypes in adults.
- Age-stratified analyses suggest PCV15 may offer greater benefits for older adults.
- Direct comparative trials and real-world effectiveness studies are needed to confirm these findings.
Abstract:
Higher-valent pneumococcal conjugate vaccines (PCV) may reduce adult pneumococcal disease, but no head-to-head trials compare PCV20 vs. PCV15 in adults. We synthesized serotype-specific immunogenicity from randomized controlled trials using a network meta-analysis via the common comparator PCV13. PubMed, Scopus, Cochrane Library, and ClinicalTrials.gov were searched for trials enrolling adults (≥18 y) and evaluating PCV20 or PCV15. The primary endpoint was opsonophagocytic activity (OPA) geometric mean titers (GMTs) at 30 d, summarized as ratios of means on the log scale. Heterogeneity/inconsistency were assessed and prespecified age-stratified analyses were performed where possible. Seventeen trials met inclusion criteria but nine contributed OPA data for 15 serotypes. Across most shared serotypes, PCV20 elicited comparable or lower OPA responses than PCV15, with significantly higher responses for PCV15 for several serotypes, including 3. PCV20 exceeded PCV15 only for serotype 4. Age-stratified results suggested greater relative advantages for PCV15 in older adults. Direct comparative and real-world effectiveness studies are needed.
More Related Videos
Related Concept Videos
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Vaccines
Vaccinations
Streptococcal Pharyngitis

